Garden Biopharma reveals results for 2023 and Q1 2024

On 16 April, Zhejiang Garden Biopharmaceutical Co., Ltd. (Garden Biopharma) revealed the results for 2023 and Q1 2024.Operating revenue for 2023 totalled USD154.31 million (RMB1.09 billion), down 22.78% YoY. Net profit attributable to shareholders fo...

Vitamins China E-News 202404

www.cnchemicals.com